Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Oct 04 04:00PM ET
2.10
Dollar change
+0.01
Percentage change
0.48
%
Index- P/E- EPS (ttm)-2.97 Insider Own0.00% Shs Outstand3.65M Perf Week-1.87%
Market Cap7.66M Forward P/E- EPS next Y- Insider Trans- Shs Float3.65M Perf Month0.09%
Income-10.84M PEG- EPS next Q- Inst Own6.90% Short Float0.18% Perf Quarter0.00%
Sales11.39M P/S0.67 EPS this Y- Inst Trans-54.00% Short Ratio0.57 Perf Half Y4.53%
Book/sh3.64 P/B0.58 EPS next Y- ROA-45.97% Short Interest0.01M Perf Year7.28%
Cash/sh3.78 P/C0.56 EPS next 5Y- ROE-59.00% 52W Range1.55 - 2.75 Perf YTD12.90%
Dividend Est.- P/FCF- EPS past 5Y47.79% ROI-81.47% 52W High-23.63% Beta1.00
Dividend TTM- Quick Ratio6.33 Sales past 5Y1021.65% Gross Margin90.62% 52W Low35.48% ATR (14)0.13
Dividend Ex-Date- Current Ratio6.33 EPS Y/Y TTM39.09% Oper. Margin-76.37% RSI (14)51.29 Volatility4.30% 6.26%
Employees22 Debt/Eq0.00 Sales Y/Y TTM64.55% Profit Margin-95.18% Recom1.00 Target Price10.00
Option/ShortNo / Yes LT Debt/Eq0.00 EPS Q/Q-52.29% Payout- Rel Volume0.15 Prev Close2.09
Sales Surprise- EPS Surprise- Sales Q/Q-15.84% EarningsAug 13 BMO Avg Volume11.16K Price2.10
SMA202.03% SMA50-0.26% SMA2007.29% Trades Volume1,629 Change0.48%
Date Action Analyst Rating Change Price Target Change
Feb-09-18Initiated H.C. Wainwright Buy $5
Aug-13-24 09:05AM
May-29-24 08:45AM
May-15-24 09:35AM
May-10-24 01:53PM
08:05AM
10:54PM Loading…
Mar-28-24 10:54PM
09:05AM
Jan-08-24 09:00AM
Nov-09-23 09:05AM
Sep-19-23 09:05AM
Aug-23-23 09:05AM
Aug-10-23 09:05AM
Jul-11-23 09:05AM
Jun-15-23 09:20AM
May-24-23 09:05AM
09:05AM Loading…
May-12-23 09:05AM
May-02-23 09:05AM
Mar-30-23 09:05AM
Feb-06-23 09:10AM
Jan-25-23 09:05AM
Jan-23-23 09:05AM
Jan-04-23 09:05AM
Nov-10-22 09:05AM
Sep-26-22 09:00AM
Aug-08-22 09:05AM
Jul-12-22 09:00AM
May-12-22 09:05AM
Mar-29-22 09:05AM
Mar-21-22 08:05AM
Mar-17-22 04:05PM
09:31AM Loading…
Mar-01-22 09:31AM
09:00AM
Feb-24-22 04:05PM
Feb-02-22 11:28AM
Feb-01-22 09:00AM
Dec-17-21 04:30PM
Dec-15-21 08:00AM
Nov-17-21 03:01AM
Nov-10-21 04:15PM
Nov-09-21 09:00AM
Nov-04-21 03:01PM
Nov-02-21 02:20PM
Aug-14-21 03:57AM
Aug-10-21 09:10AM
04:38AM
Jul-30-21 03:00PM
Jul-27-21 10:00AM
May-11-21 04:35PM
Apr-15-21 09:15AM
Apr-12-21 05:41PM
09:00AM
Mar-23-21 09:05AM
Mar-04-21 09:15AM
Feb-16-21 01:30PM
Feb-11-21 12:24AM
Nov-12-20 09:00AM
Nov-09-20 01:39PM
Oct-21-20 09:00AM
Sep-30-20 08:30AM
Sep-29-20 08:30AM
Sep-22-20 08:30AM
Aug-07-20 09:00AM
Jul-08-20 08:30AM
Jun-26-20 09:00AM
May-27-20 09:00AM
May-14-20 09:00AM
Apr-29-20 10:02AM
Apr-16-20 05:25PM
08:30AM
Mar-26-20 09:00AM
Jan-31-20 07:20AM
Jan-30-20 08:00AM
Jan-16-20 12:05PM
Jan-06-20 08:58AM
Jan-03-20 09:55AM
Jan-02-20 08:51AM
Nov-04-19 09:15AM
Nov-01-19 09:00AM
Sep-18-19 09:30AM
Aug-19-19 09:25AM
Aug-05-19 09:00AM
Jun-07-19 10:25AM
Jun-06-19 06:42AM
May-16-19 09:10AM
May-15-19 09:00AM
Apr-15-19 09:00AM
Apr-08-19 04:29PM
Apr-03-19 09:30PM
Apr-01-19 05:33PM
02:34PM
09:00AM
Mar-14-19 09:45AM
Mar-12-19 12:22PM
Mar-08-19 01:00PM
Feb-19-19 09:00AM
Feb-12-19 09:30AM
Feb-08-19 07:00AM
Feb-07-19 09:00AM
Feb-06-19 12:15PM
09:00AM
Pulmatrix, Inc. is a clinical stage biotechnology company, which engages in the development and discovery of novel inhaled therapeutics products. The company was founded by David Alan Edwards, Mark J. Gabrielson, Alexander M. Klibanov, and Robert S. Langer, Jr. in April 2003 and is headquartered in Framingham, MA.